Factors Influencing the Use of Antitumoral Chemotherapy in the South East of England

References

• Department of Health (DoH). A policy framework for commissioning cancer services: A report by the Expert Advisory Group on cancer to the Chief Medical Officers of England and Wales. London; Department of Health 1995
   Google Scholar
• Department of Health (DoH). The Cancer Plan. London; Department of Health 2000
   Google Scholar
• Department of Health (DoH). The NHS Plan. London; Department of Health 2000
   Google Scholar
• Cancer Research UK. CancerStats Incidence UK. Cancer Research UK, London. http:www.cancerresearchuk.org/statistics
   Google Scholar
• Bach PB, Cramer LD, Warren JL, Begg CB. Racial dif-ferences in the treatment of early-stage lung cancer. N Engl J Med 1999; 341: 1198–1205
   PubMed Web of Science ®Google Scholar
• Hershman D, Weinberg M, Rosner Z et al. Ethnic neu-tropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst 2003; 95: 1545–1548
   Google Scholar
• Govindarajan R, Shah RV, Erkman LG, Hutchins LF. Racial differences in the outcome of patients with colorectal carcinoma. Cancer 2003; 97: 493–498
   PubMed Web of Science ®Google Scholar
• Ganz PA. Age and gender as factors in cancer therapy. Clin Geriatr Med 1993; 9: 145–155
   PubMedGoogle Scholar
• Sloan JA, Goldberg RM, Sargent DJ et al. Women experience greater toxicity with fluorouracil-based chemothera-py for colorectal cancer. J Clin Oncol 2002; 20: 1491–1441
   Google Scholar
• Tarbell NJ, Gelber RD, Weinstein HJ, Mauch P. Sex differences in risk of second malignant tumours after Hodgkin's disease in childhood. Lancet 1993; 341: 1428–1432
   PubMed Web of Science ®Google Scholar
• Bennett CL, Greenfield S, Aronow H, Ganz P, Vogelzang NJ, Elashoff RM. Patterns of care related to age of men with prostate cancer. Cancer 1991; 67: 2633–2641
   PubMed Web of Science ®Google Scholar
• Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of stan-dard adjuvant therapy for colorectal cancer. J Clin Oncol 2002; 20: 1192–1202
   PubMed Web of Science ®Google Scholar
• Rose JH, O'Toole EE, Dawson NV et al. Age differ-ences in care practices and outcomes for hospitalised patients with cancer. J Am Geriatr Soc 2000; 48: S25–32
   Google Scholar
• Lantz PM, House JS, Lepkowski JM, William DR, Mero RP, Chen J. Socioeconomic factors, health behaviours, and mortality. JAMA 1998; 279: 1703–1708
   PubMed Web of Science ®Google Scholar
• Bungay H. Cancer and Health Policy: The Postcode lot-tery of Care. Social Policy and Administration 2005; 39: 35–48
   Web of Science ®Google Scholar
• Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localised breast cancer. N Engl J Med 1992; 326: 1097–1101
   PubMed Web of Science ®Google Scholar
• Grothey A, Kellermann L, Schmoll HJ. Deficits in man-agement of patients with colorectal carcinoma in Germany. Results of multicentre documentation of therapy algorithms. Med Klin 2002; 97: 270–277
   Google Scholar
• Richards MA, Stockton D, Babb P, Coleman MP. How many deaths have been avoided through improvements in cancer survival? BMJ 2000; 320: 895–898
   PubMed Web of Science ®Google Scholar
• Munro AJ. The Calman-Hine report: its causes and its consequences. Eur J Cancer Care 2001; 10: 212–220
   PubMed Web of Science ®Google Scholar
• Chouillet AM, Bell CMJ, Hiscox JG. Management of breast cancer in southeast England. BMJ 1994; 308: 168–171
   PubMedGoogle Scholar
• Sainsbury R, Haward B, Rider L, Johnston C, Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 1995; 345: 1265–1270
   PubMed Web of Science ®Google Scholar
• Ottevanger PB, De Mulder PHM, Grol RP, Van Lier H, Beex LV. Adherence to the guidelines of the CCCE in the treatment of node-positive breast cancer patients. Eur J Cancer 2004; 35: 386–391
   Web of Science ®Google Scholar
• Hillner BE, McDonald MK, Penberthy L, Desch CE, Smith TJ, Maddux P. Measuring standards of care for early breast cancer in an insured population. J Clin Oncol 1997; 15: 1401–1408
   PubMed Web of Science ®Google Scholar
• Engel J, Nagel G, Breuer E et al. Primary breast cancer therapy in six regions of Germany. Eur J Cancer 2002; 38: 578–585
   Web of Science ®Google Scholar
• Schrag D, Cramer LD, Back PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001; 93: 850–857
   PubMed Web of Science ®Google Scholar
• Newcomb PA, Carbone PP. Cancer treatment and age: patient perspectives. J Natl Cancer Inst 1993; 85: 1580–1584
   PubMed Web of Science ®Google Scholar
• Earle CC, Neumann PJ, Gelber RD, Weinstein MC, Weeks JC. Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol 2002; 20: 1786–1792
   PubMed Web of Science ®Google Scholar
• Greenberg ER, Chute CG, Stukel T et al. Social and economic factors in the choice of lung cancer treatment: A population-based study in two rural states. N Eng J Med. 1988; 318: 612–617
   Google Scholar
• Greenberg ER, Dain B, Freeman D, Yates J, Korson R. Referral of lung cancer patients to University hospital cancer centres: A population-based study in two rural states. Cancer 1988; 62: 1647–1652
   PubMed Web of Science ®Google Scholar
• Gradishar WJ, Kaklamani VG. Adjuvant therapy of breast cancer in the elderly. JAMA 2005; 293: 1118–1120
   PubMed Web of Science ®Google Scholar
• DeMichele A, Putt M, Zhang Y, Glick JH, Norman S. Older age predicts a decline in adjuvant chemotherapy recom- mendations for patients with breast carcinoma. Cancer 2003; 97: 2150–2159
   PubMed Web of Science ®Google Scholar
• Hart CL, Hole DJ, Gillis CR, Davey Smith G, Watt GCM, Hawthorne VM. Social class differences in lung cancer mortality: risk factor explanations using two Scottish cohort studies. Int. J. Epidemiol 2001; 30: 268–274
   PubMed Web of Science ®Google Scholar
• Coleman MP, Rachet B, Woods LM et al. Trends and socioeconomic equalities in cancer survival in England and Wales up to 2001. Br J Cancer 2004; 90: 1367–1373
   Google Scholar